These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16040209)

  • 1. Myocardial infarction risk and hormone replacement: differences between products.
    de Vries CS; Bromley SE; Farmer RD
    Maturitas; 2006 Feb; 53(3):343-50. PubMed ID: 16040209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study.
    Renoux C; Dell'aniello S; Garbe E; Suissa S
    BMJ; 2010 Jun; 340():c2519. PubMed ID: 20525678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current use of unopposed estrogen and estrogen plus progestin and the risk of acute myocardial infarction among women with diabetes: the Northern California Kaiser Permanente Diabetes Registry, 1995-1998.
    Ferrara A; Quesenberry CP; Karter AJ; Njoroge CW; Jacobson AS; Selby JV;
    Circulation; 2003 Jan; 107(1):43-8. PubMed ID: 12515741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women.
    Psaty BM; Smith NL; Lemaitre RN; Vos HL; Heckbert SR; LaCroix AZ; Rosendaal FR
    JAMA; 2001 Feb; 285(7):906-13. PubMed ID: 11180734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
    Norman RJ; Flight IH; Rees MC
    Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study.
    Varas-Lorenzo C; García-Rodríguez LA; Perez-Gutthann S; Duque-Oliart A
    Circulation; 2000 Jun; 101(22):2572-8. PubMed ID: 10840007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of cardiovascular outcomes in users of estradiol/dydrogesterone or other HRT preparations.
    Schneider C; Jick SS; Meier CR
    Climacteric; 2009 Oct; 12(5):445-53. PubMed ID: 19565370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up.
    Alexander KP; Newby LK; Hellkamp AS; Harrington RA; Peterson ED; Kopecky S; Langer A; O'Gara P; O'Connor CM; Daly RN; Califf RM; Khan S; Fuster V
    J Am Coll Cardiol; 2001 Jul; 38(1):1-7. PubMed ID: 11451256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
    Beral V; Bull D; Reeves G;
    Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women.
    Thompson SG; Meade TW; Greenberg G
    J Epidemiol Community Health; 1989 Jun; 43(2):173-8. PubMed ID: 2592907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer and hormone-replacement therapy in the Million Women Study.
    Beral V;
    Lancet; 2003 Aug; 362(9382):419-27. PubMed ID: 12927427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tibolone and endometrial cancer: a cohort and nested case-control study in the UK.
    de Vries CS; Bromley SE; Thomas H; Farmer RD
    Drug Saf; 2005; 28(3):241-9. PubMed ID: 15733028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1997 Apr; 349(9060):1202-9. PubMed ID: 9130941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal hormone use in women with acute coronary syndromes.
    Parsons E; Newby LK; Bhapkar MV; Alexander KP; White HD; Shah SH; Bushnell CD; Califf RM;
    J Womens Health (Larchmt); 2004 Oct; 13(8):863-71. PubMed ID: 15671702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy and risk of non-fatal stroke.
    Pedersen AT; Lidegaard O; Kreiner S; Ottesen B
    Lancet; 1997 Nov; 350(9087):1277-83. PubMed ID: 9357407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post menopausal hormone replacement therapy and risk of acute myocardial infarction--a case control study of women in the East Midlands, UK.
    Chilvers CE; Knibb RC; Armstrong SJ; Woods KL; Logan RF
    Eur Heart J; 2003 Dec; 24(24):2197-205. PubMed ID: 14659771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women.
    Psaty BM; Heckbert SR; Atkins D; Lemaitre R; Koepsell TD; Wahl PW; Siscovick DS; Wagner EH
    Arch Intern Med; 1994 Jun; 154(12):1333-9. PubMed ID: 8002685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy and myocardial infarction and stroke in postmenopausal Korean women.
    Baek JK; Kim HY; Kang MJ; Choi EA; Lee JK; Kim EH; Seo SK
    Climacteric; 2024 Aug; 27(4):406-412. PubMed ID: 38990048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy use and the risk of stroke.
    Renoux C; Dell'aniello S; Garbe E; Suissa S
    Maturitas; 2008 Dec; 61(4):305-9. PubMed ID: 18996656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.